Stay updated on Cabozantinib + Atezolizumab vs Sorafenib in Advanced HCC Clinical Trial
Sign up to get notified when there's something new on the Cabozantinib + Atezolizumab vs Sorafenib in Advanced HCC Clinical Trial page.

Latest updates to the Cabozantinib + Atezolizumab vs Sorafenib in Advanced HCC Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoChange DetectedNapoli, Italy, 80131 was replaced with Naples, Italy, 80131 in the locations list. The page revision was updated from v3.4.3 to v3.5.0.SummaryDifference0.0%

- Check15 days agoChange DetectedHepatocellular carcinoma keyword added; Genetic and Rare Diseases Information Center added to Resources.SummaryDifference0.0%

- Check22 days agoChange DetectedRevision: v3.4.3 has been added to the page footer. Revision: v3.4.2 has been removed.SummaryDifference0.0%

- Check44 days agoChange DetectedThe page now displays Revision: v3.4.2, replacing the previous Revision: v3.4.1.SummaryDifference0.0%

- Check51 days agoChange DetectedAdded Revision: v3.4.1 and removed the prior Revision: v3.4.0 notice along with the old government funding status message. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check58 days agoChange DetectedA site-wide notice about a lapse in government funding was added, stating that information may not be up to date and directing users to cc.nih.gov and opm.gov for status; To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

Stay in the know with updates to Cabozantinib + Atezolizumab vs Sorafenib in Advanced HCC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Cabozantinib + Atezolizumab vs Sorafenib in Advanced HCC Clinical Trial page.